Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | Nutriband's six month revenue jumps 51% YY | 1 | Seeking Alpha | ||
Mi | Nutriband reports 50.87% revenue growth for first half of 2025 | 3 | Investing.com | ||
Mi | Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl | 72 | GlobeNewswire (Europe) | ORLANDO, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) reported its financial results for the six months ended July 31, 2025. The company reported a strong cash... ► Artikel lesen | |
09.09. | NutriBand Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
NUTRIBAND Aktie jetzt für 0€ handeln | |||||
03.09. | Nutriband announces exercise of warrants at $6.43 for gross proceeds of $5.31M | 1 | Seeking Alpha | ||
03.09. | NutriBand Inc. - 8-K, Current Report | 1 | SEC Filings | ||
11.08. | Nutriband CEO Steps Down Temporarily; FDA Meeting Granted For AVERSA Fentanyl | - | RTTNews | ||
11.08. | Nutriband CEO Gareth Sheridan, 35, enters presidential race | 1 | BreakingNews.ie | ||
11.08. | Nutriband Inc.: Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election | 149 | GlobeNewswire (Europe) | Sheridan will temporarily step aside as CEO to enter the Irish Presidential Election. Company Chairman and President, Serguei Melnik will take over as interim CEO over the course of the campaign... ► Artikel lesen | |
08.08. | FDA to meet with Nutriband on abuse-deterrent fentanyl patch | 1 | Investing.com | ||
08.08. | Nutriband stock rises after FDA grants meeting for fentanyl patch | 3 | Investing.com | ||
08.08. | Nutriband Inc.: FDA Grants Nutriband Meeting Request for Aversa Fentanyl Abuse Deterrent Fentanyl Patch | 179 | GlobeNewswire (Europe) | FDA grants meeting for AVERSA FENTANYL (abuse deterrent transdermal system) to provide feedback on the Chemistry, Manufacturing, and Controls plans for the product through commercialization. Nutriband... ► Artikel lesen | |
07.08. | NutriBand Inc. - 8-K, Current Report | 1 | SEC Filings | ||
18.07. | Nutriband announces key dates for 25% preferred stock dividend | 1 | Investing.com | ||
18.07. | Nutriband Inc.: Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval | 1 | GlobeNewswire (USA) | ||
16.07. | NutriBand genehmigt neue Vorzugsaktien der Serie A und kündigt Dividende an | 2 | Investing.com Deutsch | ||
02.07. | Nutriband declares 25% preferred stock dividend for shareholders | 1 | Investing.com | ||
02.07. | Nutriband kündigt 25% Vorzugsaktien-Dividende für Aktionäre an | 5 | Investing.com Deutsch | ||
02.07. | Nutriband Inc.: Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval | 243 | GlobeNewswire (Europe) | ORLANDO, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) ("Nutriband" or the "Company") announced today that its Board of Directors has approved and declared a... ► Artikel lesen | |
01.07. | Nutriband added to the Russell Microcap index, Russell Microcap Growth index, Russell 3000E index and Russell 3000E growth index | 1 | Seeking Alpha |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BAYER | 27,500 | -2,03 % | Bayer-Aktie mit Kursverlusten (27,985 €) | Im deutschen Wertpapierhandel notiert das Wertpapier von Bayer gegenwärtig etwas leichter. Der jüngste Kurs betrug 27,99 Euro. Das Wertpapier von Bayer verzeichnet derzeit einen Kursrückgang von 0,60... ► Artikel lesen | |
NOVO NORDISK | 47,265 | -0,16 % | Übernahmekandidat! Novo Nordisk und Eli Lilly bei BioNxt Solutions auf der Lauer | Eine Depotrakete für die kommenden Wochen? Da ist die Aktie von BioNxt Solutions mindestens einen Blick wert. Denn von Sommerloch konnte bei dem Unternehmen keine Rede sein. Stattdessen ging es Schlag... ► Artikel lesen | |
PFIZER | 20,365 | -0,02 % | Investor Woche: EZB hält Zinsen stabil, Fed vor Dilemma, Klarna mit starkem IPO, Novo Nordisk streicht stellen, Pfizer, Prismo Metals, Sotheby's, Larry Ellison, Elon Musk | EZB belässt Zinsen stabil. Die Fed dürfte kommende Woche trotz hartnäckiger Inflation wegen dem schwachen Arbeitsmarkt die Zinsen senken. Klarna mit starkem IPO, Sotheby's leidet am Kunstmarkt. Novo... ► Artikel lesen | |
GILEAD SCIENCES | 95,79 | +0,14 % | Dividendenbekanntmachungen (15.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A&W FOOD SERVICES OF CANADA INC CA0002251027 0,48 CAD 0,2954 EUR ALLEGION PLC IE00BFRT3W74 0,51 USD 0,4345 EUR ALTRIA GROUP INC US02209S1033 1... ► Artikel lesen | |
GSK | 17,150 | -1,72 % | Research and Markets: Europe Liver Disease Therapeutic Market Analysis Report 2025-2033 Featuring Abbott, Astellas, BMS, Gilead Sciences, GSK, F. Hoffman-La Roche, Merck & Co., Novartis, Sanofi, Pfizer, Takeda - ResearchAndMarkets.com | The "Europe Liver Disease Therapeutic Market Forecast 2025" report has been added to ResearchAndMarkets.com's offering.
The Europe Liver Disease Therapeutic Market is expected to grow from US$... ► Artikel lesen | |
ROCHE | 278,60 | -0,07 % | Kein Tabu mehr? Auch Roche und Novartis wollen Löhne offenlegen | ||
ELI LILLY | 635,90 | -0,69 % | Pharma Giant Eli Lilly (LLY) Could Still Be a Screaming Deal-Here's the Statistical Evidence | ||
MERCK & CO | 69,00 | +0,15 % | Daiichi Sankyo, Merck Say Raludotatug Deruxtecan Granted Breakthrough Therapy Designation | KENILWORTH (NJ) (dpa-AFX) - Daiichi Sankyo Company Limited (DSKYF) and Merck & Co Inc. (MRK)
said on Monday that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy... ► Artikel lesen | |
HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
TILRAY BRANDS | 1,000 | -0,70 % | UNGLAUBLICHE Sondermeldung bei Tilray Aktie: DAS erwischt Anleger heute eiskalt. Dringend lesen und reagieren! | ||
TEVA | 16,200 | +0,93 % | Teva Pharmaceutical Industries Ltd: Teva's Emrusolmin Granted U.S. FDA Fast Track Designation for Treatment of Multiple System Atrophy | Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational treatment for Multiple System Atrophy (MSA) in Phase 2 development.New... ► Artikel lesen | |
VERTEX PHARMACEUTICALS | 334,70 | +0,13 % | Vertex Pharmaceuticals Incorporated: Vertex Scientists Awarded the 2025 Lasker~DeBakey Clinical Medical Research Award for Pioneering Discoveries in Cystic Fibrosis | Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Senior Vice President Paul Negulescu has been named as one of the winners of this year's Lasker~DeBakey Clinical Medical Research... ► Artikel lesen | |
INNOCAN PHARMA | 6,600 | +3,12 % | Scheinwerfer an: Warum InnoCan Pharma jetzt im Doppel-Fokus steht! | ||
TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | Malawi: RBM Unveils Bold Plan to Safeguard Forex Gains Beyond Tobacco Season | ||
BIOTEST | 29,600 | 0,00 % | EQS-News: Biotest AG: Die Biotest AG erhält ein Einberufungsverlangen von Grifols S.A. für eine außerordentliche Hauptversammlung | EQS-News: Biotest AG
/ Schlagwort(e): Rechtssache
Die Biotest AG erhält ein Einberufungsverlangen von Grifols S.A. für eine außerordentliche Hauptversammlung
04.08.2025... ► Artikel lesen |